Disable ads (and more) with a membership for a one time $2.99 payment
CAPTIA EIA and Rapid Plasma Reagin, or RPR, are used to test for which infection?
HIV/ I/II.
Hepatitis C.
COVID-19.
Syphilis.
The correct answer is: Syphilis.
The CAPTIA Enzyme Immunoassay (EIA) and the Rapid Plasma Reagin (RPR) tests are specifically used to screen for syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum. The RPR test is a non-treponemal test that detects the presence of antibodies produced in response to the infection. On the other hand, the CAPTIA EIA is a treponemal test that detects antibodies that are specific to Treponema pallidum. Both tests are commonly employed in clinical settings to diagnose syphilis. The presence of antibodies confirms exposure to the infection, and when used together, these tests can enhance diagnostic accuracy by confirming a positive result from one type of test with a different testing approach. The other options pertain to infections that are not detected through these specific tests, illustrating the targeted nature of the CAPTIA EIA and RPR in diagnosing syphilis.